Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1988 1
1989 2
1990 2
1994 1
1995 1
1996 6
1997 3
1998 5
1999 7
2000 6
2001 2
2002 2
2003 5
2004 9
2005 7
2006 5
2007 12
2008 14
2009 12
2010 7
2011 1
2012 4
2013 4
2014 5
2015 10
2016 5
2017 7
2018 5
2019 7
2020 6
2021 6
2022 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Mechanisms of Disease: Inflammatory Bowel Diseases.
Ramos GP, Papadakis KA. Ramos GP, et al. Among authors: papadakis ka. Mayo Clin Proc. 2019 Jan;94(1):155-165. doi: 10.1016/j.mayocp.2018.09.013. Mayo Clin Proc. 2019. PMID: 30611442 Free PMC article. Review.
Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge.
Murray JA, Syage JA, Wu TT, Dickason MA, Ramos AG, Van Dyke C, Horwath I, Lavin PT, Mäki M, Hujoel I, Papadakis KA, Bledsoe AC, Khosla C, Sealey-Voyksner JA; CeliacShield Study Group. Murray JA, et al. Among authors: papadakis ka. Gastroenterology. 2022 Dec;163(6):1510-1521.e6. doi: 10.1053/j.gastro.2022.07.071. Epub 2022 Aug 2. Gastroenterology. 2022. PMID: 35931103 Free PMC article. Clinical Trial.
Targeting Specific Immunologic Pathways in Crohn's Disease.
Ramos GP, Faubion WA, Papadakis KA. Ramos GP, et al. Among authors: papadakis ka. Gastroenterol Clin North Am. 2017 Sep;46(3):577-588. doi: 10.1016/j.gtc.2017.05.009. Epub 2017 Jul 19. Gastroenterol Clin North Am. 2017. PMID: 28838416 Review.
Pharmacogenetics of inflammatory bowel disease.
Katsanos KH, Papadakis KA. Katsanos KH, et al. Among authors: papadakis ka. Pharmacogenomics. 2014 Dec;15(16):2049-62. doi: 10.2217/pgs.14.154. Pharmacogenomics. 2014. PMID: 25521361 Review.
Musculoskeletal manifestations of inflammatory bowel disease.
Bourikas LA, Papadakis KA. Bourikas LA, et al. Among authors: papadakis ka. Inflamm Bowel Dis. 2009 Dec;15(12):1915-24. doi: 10.1002/ibd.20942. Epub 2009 Apr 30. Inflamm Bowel Dis. 2009. PMID: 19408334 Review.
Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ, Basseri B, Papadakis KA. Basseri RJ, et al. Among authors: papadakis ka. Expert Rev Gastroenterol Hepatol. 2011 Feb;5(1):59-66. doi: 10.1586/egh.10.77. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21309672 Review.
Vulvar Crohn's Disease: Clinical Features and Outcomes.
Cho JM, Loftus EV Jr, Bruining DH, Chedid VG, Farraye FA, Faubion WA Jr, Johnson AM, Kane SV, Kisiel JB, Malik TA, Papadakis KA, Pardi DS, Picco MF, Raffals LE, Schroeder KW, Tremaine WJ, Coelho-Prabhu N. Cho JM, et al. Among authors: papadakis ka. Am J Gastroenterol. 2021 Nov 1;116(11):2296-2299. doi: 10.14309/ajg.0000000000001502. Am J Gastroenterol. 2021. PMID: 34732676
159 results